Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems

Current Drug Delivery

Volumn 3, Issue 1, 2006, Pages 115-120

  Singh, Manmohan ^a   Kazzaz, Jina ^a   Ugozzoli, Mildred ^a   Malyala, Padma ^a   Chesko, James ^a   O'Hagan, Derek T ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adjuvants; Microparticles; PLG; Vaccine delivery systems

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANIONIC SURFACTANT; CATIONIC SURFACTANT; DNA VACCINE; DOCUSATE SODIUM; FREUND ADJUVANT; GLYCOPROTEIN GP 120; HEXADECANOL; MEMBRANE ANTIGEN; MURAMYL DIPEPTIDE; OLIGONUCLEOTIDE; PLASMID DNA; POLYGLACTIN; QS 21; RECOMBINANT PROTEIN; TRIMETHYLAMMONIUM SALT DERIVATIVE; VACCINE; ANTIGEN; DNA; DRUG CARRIER; IMMUNOLOGICAL ADJUVANT; MICROSPHERE;

ADSORPTION; ANTIGEN BINDING; ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELECTRICITY; HUMAN; HYDROPHOBICITY; IMMUNE RESPONSE; IMMUNIZATION; MICROENCAPSULATION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; ANIMAL; METABOLISM; METHODOLOGY; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADSORPTION; ANIMALS; ANTIGENS; DNA; DRUG CARRIERS; HUMANS; MICROSPHERES; POLYGLACTIN 910; VACCINATION; VACCINES, DNA;

EID: 33644971704     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720106775197565     Document Type: Review

References (55)

1. O'Hagan, D.T. Microparticles as oral vaccines. Novel Delivery Systems for Oral Vaccines; CRC Press, Inc.: Boca Raton, 1994; pp 175-205.
2. Okada, H.; Toguchi, H. Crit. Rev. Ther. Drug Carrier Syst., 1995, 12, 1-99.
3. Putney, S.D.; Burke, P.A. Nat. Biotechnol., 1998, 16, 153-157.
4. Eldridge, J.H.; Staas, J.K.; Meulbroek, J.A.; Tice, T.R.; Gilley, R.M. Infect. Immun., 1991, 59, 2978-2986.
5. O'Hagan, D.T.; Rahman, D.; McGee, J.P.; Jeffery, H.; Davies, M.C.; Williams, P.; Davis, S.S.; Challacombe, S.J. Immunol., 1991, 73, 239-242.
6. Singh, M.; Singh, A.; Talwar, G.P. Pharm. Res., 1991, 8, 958-961.
7. O'Hagan, D.T.; Jeffery, H.; Roberts, M.J.; McGee, J.P.; Davis, S.S. Vaccine, 1991, 9, 768-771.
8. Maloy, K.J.; Donachie, A.M.; O'Hagan, D.T.; Mowat, A.M. Immunol., 1994, 81, 661-667.
9. Moore, A.; McGuirk, P.; Adams, S.; Jones, W.C.; McGee, J.P.; O'Hagan, D.T.; Mills, K.H. Vaccine, 1995, 13, 1741-1749.
10. Nixon, D.F.; Hioe, C.; Chen, P.D.; Bian, Z.; Kuebler, P.; Li, M.L.; Qiu, H.; Li, X.M.; Singh, M.; Richardson, J.; McGee, P.; Zamb, T.; Koff, W.; Wang, C.Y.; O'Hagan, D. Vaccine, 1996, 14, 1523-1530.
11. Kanke, M.; Sniecinski, I.; DeLuca, P.P. J. Parenter. Sci. Technol., 1983, 37, 210-217.
12. Tabata, Y.; Ikada, Y. J. Biomed. Mater. Res., 1988, 22, 837-858.
13. Tabata, Y.; Ikada, Y. Advances in Polymer Science , 1990, 94, 107-141.
14. Randolph, G.J.; Inaba, K.; Robbiani, D.F.; Steinman, R.M.; Muller, W.A. Immunity., 1999, 11, 753-761.
15. Lutsiak, M.E.; Robinson, D.R.; Coester, C.; Kwon, G.S.; Samuel, J. Pharm. Res., 2002, 19, 1480-1487.
16. Newman, K.D.; Elamanchili, P.; Kwon, G.S.; Samuel, J. J. Biomed. Mater. Res., 2002, 60, 480-486.
17. O'Hagan, D.T.; Jeffery, H.; Davis, S.S. Vaccine, 1993, 11, 965-969.
18. O'Hagan, D.T.; Ugozzoli, M.; Barackman, J.; Singh, M.; Kazzaz, J.; Higgins, K.; VanCott, T.C.; Ott, G. Vaccine, 2000, 18, 1793-1801.
19. Kazzaz, J.; Neidleman, J.; Singh, M.; Ott, G.; O'Hagan, D.T. J Control Release, 2000, 67, 347-356.
20. Singh, M.; Chesko, J.; Kazzaz, J.; Ugozzoli, M.; Kan, E.; Srivastava, I.; O'Hagan, D. Pharm. Res., 2004, 21, 2148-2152.
21. Jung, T.; Kamm, W.; Breitenbach, A.; Hungerer, K.D.; Hundt, E.; Kissel, T. Pharm. Res., 2001, 18, 352-360.
22. O'Hagan, D.T.; Jeffery, H.; Davis, S.S. Vaccine, 1993, 11, 965-969.
23. Otten, G.R.; Doe, B.; Schaefer, M.; Chen, M.; Selby, M.J.; Goldbeck, C.; Hong, M.; Xu, F.; Ulmer, J.B. Intervirology, 2000, 43, 227-232.
24. Seder, R.A.; Gurunathan, S. N. Engl. J. Med., 1999, 341, 277-278.
25. Wang, R.; Doolan, D.L.; Le, T.P.; Hedstrom, R.C.; Coonan, K.M.; Charoenvit, Y.; Jones, T.R.; Hobart, P.; Margalith, M.; Ng, J.; Weiss, W.R.; Sedegah, M.; de Taisne, C.; Norman, J.A.; Hoffman, S.L. Science, 1998, 282, 476-480.
26. Calarota, S.; Bratt, G.; Nordlund, S.; Hinkula, J.; Leandersson, A.C.; Sandstrom, E.; Wahren, B. Lancet, 1998, 351, 1320-1325.
27. Schneider, J.; Gilbert, S.C.; Blanchard, T.J.; Hanke, T.; Robson, K.J.; Hannan, C.M.; Becker, M.; Sinden, R.; Smith, G.L.; Hill, A.V. Nat. Med., 1998, 4, 397-402.
28. Sullivan, N.J.; Sanchez, A.; Rollin, P.E.; Yang, Z.Y.; Nabel, G.J. Nature, 2000, 408, 605-609.
29. Amara, R.R.; Villinger, F.; Altman, J.D.; Lydy, S.L.; O'Neil, S.P.; Staprans, S.I.; Montefiori, D.C.; Xu, Y.; Herndon, J.G.; Wyatt, L.S.; Candido, M.A.; Kozyr, N.L.; Earl, P.L.; Smith, J.M.; Ma, H.L.; Grimm, B.D.; Hulsey, M.L.; Miller, J.; McClure, H.M.; McNicholl, J.M.; Moss, B.; Robinson, H.L. Science, 2001, 292, 69-74.
30. Hedley, M.L.; Curley, J.; Urban, R. Nat. Med., 1998, 4, 365-368.
31. Walter, E.; Moelling, K.; Pavlovic, J.; Merkle, H.P., 1999, 61, 361-374.
32. Ando, S.; Putnam, D.; Pack, D.W.; Langer, R. J. Pharm. Sci., 1999, 88, 126-130.
33. Tinsley-Bown, A.M.; Fretwell, R.; Dowsett, A.B.; Davis, S.L.; Farrar, G.H. J. Controlled Release, 2000, 66, 229-241.
34. Singh, M.; Briones, M.; Ott, G.; O'Hagan, D. Proc. Natl. Acad. Sci. USA, 2000, 97, 811-816.
35. Briones, M.; Singh, M.; Ugozzoli, M.; Kazzaz, J.; Klakamp, S.; Ott, G.; O'Hagan, D. Pharm. Res., 2001, 18, 709-711.
36. O'Hagan, D.; Singh, M.; Ugozzoli, M.; Wild, C.; Barnett, S.; Chen, M.; Otten, G.R.; Ulmer, J.B. J. Virol., 2001, 75, 9037-9043.
37. Denis-Mize, K.S.; Dupuis, M.; MacKichan, M.L.; Singh, M.; Doe, B.; O'Hagan, D.; Ulmer, J.B.; Donnelly, J.J.; McDonald, D.M.; Ott, G. Gene Ther., 2000, 7, 2105-2112.
38. Ott, G.; Singh, M.; Kazzaz, J.; Briones, M.; Soenawan, E.; Ugozzoli, M.; O'Hagan, D.T. J. Control Release, 2002, 79, 1-5.
39. Singh, M.; Ott, G.; Kazzaz, J.; Ugozzoli, M.; Briones, M.; Donnelly, J.; O'Hagan, D.T. Pharm. Res., 2001, 18, 1476-1479.
40. Xie, H.; Gursel, I.; Ivins, B.E.; Singh, M.; O'Hagan, D.T.; Ulmer, J.B.; Klinman, D.M.; Baldrick, P.; Richardson, D.; Wheeler, A.W.; Aggerbeck, H.; Heron, I.; Miyamura, K.; Nishio, S.; Ito, A.; Murata, R.; Kono, R. Infect. Immun., 2005, 73, 828-833.
41. Tabata, Y.; Ikada, Y. J. Pharm. Pharmacol., 1987, 39, 698-704.
42. Puri, N.; Sinko, P.J. J Control Release, 2000, 69, 69-80.
43. Cleland, J.L.; Barron, L.; Daugherty, A.; Eastman, D.; Kensil, C.; Lim, A.; Weissburg, R.P.; Wrin, T.; Vennari, J.; Powell, M.F. J. Pharm. Sci., 1997, 85, 1350-1357.
44. O'Hagan, D.T. Lancet, 1991, 337, 1289.
45. O'Hagan, D.T.; Singh, M.; Kazzaz, J.; Ugozzoli, M.; Briones, M.; Donnelly, J.; Ott, G. Vaccine, 2002, 20, 3389-3398.
46. Levine, M.M.; Dougan, G. Lancet, 1998, 351, 1375-1376.
47. O'Hagan, D. Adv. Drug Deliv. Rev., 1998, 34, 305-320.
48. Vajdy, M.; O'Hagan, D.T. Adv. Drug Deliv. Rev., 2001, 51 , 127-141.
49. Singh, M.; Vajdy, M.; Gardner, J.; Briones, M.; O'Hagan, D. Vaccine, 2002, 20, 594-602.
50. Denis-Mize, K.; Dupuis, M.; Singh, M.; Woo, C.; Ugozzoli, M.; O'Hagan, D.; Donnelly, J.; Ott, G.; McDonald, D.M. Cell. Immunol., 2003, 225, 12-20.
51. Denis-Mize, K.S.; Dupuis, M.; MacKichan, M.L.; Singh, M.; Doe, B.; O'Hagan, D.; Ulmer, J.B.; Donnelly, J.J.; McDonald, D.M.; Ott, G. Gene Ther., 2000, 7, 2105-2112.
52. Park, T.G.; Lu, W.; Crotts, G. J. Controlled Release, 1995, 33, 211-219.
53. Shenderova, A.; Burke, T.G.; Schwendeman, S.P. Pharm. Res., 1999, 16, 241-248.
54. van de Weert, M.; Hennink, W.E.; Jiskoot, W. Pharm. Res., 2000, 17, 1159-1167.
55. Johnson, R.E.; Lanaski, L.A.; Gupta, V.; Griffin, M.J.; Gaud, H.T.; Needham, T.E.; Zia, H. J. Controlled Release, 1991, 17, 61.